Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

May 13, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Coronary Artery DiseasePercutaneous Coronary InterventionDual Antiplatelet Therapy

Trial Locations (1)

RECRUITING

Wonju Severance Christian Hospital, Wŏnju

All Listed Sponsors

lead

Genoss Co., Ltd.

INDUSTRY